Therapeutic Effect of the Low FODMAP Diet in Children With Functional Abdominal Pain.
Evaluation of the Effectiveness of the Low FODMAP Diet in the Treatment of Functional Abdominal Pain in Children
1 other identifier
interventional
33
1 country
2
Brief Summary
Diet components are important factors in pathogenesis of functional gastrointestinal disorders, especially in the irritable bowel syndrome. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) are a group of short chain, poorly absorbed and osmotically active carbohydrates, which can induce gastrointestinal symptoms because of rapid fermentation in different segments of the gut. Low FODMAP diet is a novel treatment option with proven efficacy in reducing symptoms of functional gastrointestinal disorders in adults. Conversely, although functional abdominal pain is a common health problem in children, the efficacy of a low FODMAP diet remains understudied in this population. The aim of this study was to compare the effects of two diets: a low FODMAP diet and a diet based on standard dietary advice of the National Institute for Health and Care Excellence (NICE), on abdominal symptoms in children with functional abdominal pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2017
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 8, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 8, 2017
CompletedFirst Submitted
Initial submission to the registry
December 6, 2018
CompletedFirst Posted
Study publicly available on registry
December 10, 2018
CompletedDecember 10, 2018
December 1, 2018
5 months
December 6, 2018
December 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of abdominal pain severity
Wong-Baker FACES Pain Rating Scale where 0 = no hurt and 10 = hurts worst was used for assessed severity of abdominal pain during the 6-week study period (2 weeks before and 4 weeks during the diet)
6 weeks
Secondary Outcomes (1)
Assessment of abdominal pain and defecation frequency
6 weeks
Other Outcomes (4)
Assessment of stool consistency
6 weeks
Assessment of nutritional status
4 months
Assessment of physical activity
4 months
- +1 more other outcomes
Study Arms (2)
Low FODMAP diet group
EXPERIMENTALfour weeks of the low FODMAP diet based on Monash University low FODMAP diet App.
Control group
ACTIVE COMPARATORfour weeks of the diet based on NICE guidelines and contained products with different FODMAP content
Interventions
The low FODMAP group had reduced the intake of FODMAP. Children received 3 main meals and 2 snacks daily prepared by the catering company according to the Human Nutrition Recommendations for Polish Population. The dietary intervention lasted four weeks.
The control group based on NICE guidelines received diet contained products with different FODMAP content. Children received 3 main meals and 2 snacks daily prepared by the catering company according to the Human Nutrition Recommendations for Polish Population. The dietary intervention lasted four weeks.
Eligibility Criteria
You may qualify if:
- functional abdominal pain according to Rome III criteria
- consent to participate in the study
- positive decision of gastroenterologist concerning enrolment of the patient to the trial
You may not qualify if:
- organic causes for gastrointestinal tract disorders,
- occurrence of an abdominal migraine, IBS, food allergies or intolerances, other significant disorders, acute infection
- antibiotic treatment within the last 8 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Warmia and Mazurylead
- National Science Centre, Polandcollaborator
Study Sites (2)
Regional Specialized Children's Hospital
Olsztyn, 10-561, Poland
University of Warmia and Mazury
Olsztyn, 10-719, Poland
Study Officials
- PRINCIPAL INVESTIGATOR
Katarzyna M Boradyn, MSc
Department of Human Nutrition, Faculty of Food Science, University of Warmia and Mazury
- PRINCIPAL INVESTIGATOR
Elżbieta Jarocka-Cyrta, Ph.D
Department of Pediatrics, Gastroenterology and Nutrition, Collegium Medicum Faculty of Medicine, University of Warmia and Mazury
- PRINCIPAL INVESTIGATOR
Katarzyna E Przybyłowicz, Ph.D
Department of Human Nutrition, Faculty of Food Science, University of Warmia and Mazury
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 6, 2018
First Posted
December 10, 2018
Study Start
July 8, 2017
Primary Completion
December 8, 2017
Study Completion
December 8, 2017
Last Updated
December 10, 2018
Record last verified: 2018-12
Data Sharing
- IPD Sharing
- Will not share